COA
- Product Details
- Performance Data
- Reviews & Citations
- Resources
1/1
No data
ID | Components | Size |
EP107-C01 | Pre-coated Human ACE2 Microplate | 1 plate |
EP107-C02 | SARS-CoV-2 Inhibitor | 10 μg |
EP107-C03 | HRP-SARS-CoV-2 Spike RBD(WT) | 15 μg |
EP107-C04 | 10xWashing Buffer | 50 mL |
EP107-C05 | Dilution Buffer | 50 mL |
EP107-C06 | Substrate Solution | 12 mL |
EP107-C07 | Stop Solution | 7 mL |
The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses continual threat to human health due to rapid transmission worldwide. The deleloped of effcient treatment agaginst SARS-CoV-2 is an emergent need for global pubic heath,and it is necessary to develop SARS-CoV-2 inhibitors, such as vaccines， therapeutic antibodies and small molecule compounds against SARS-CoV-2.
Therefore, it is helpful to develop the SARS-CoV-2 (WT) Inhibitor Screening Kit (Spike RBD) to test SARS-CoV-2 inhibitors.
This kit is developed for screening inhibitors of SARS-CoV-2 (WT).
It is for research use only.
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
1. Unopened kit should be stored at 2℃-8℃ upon receiving.
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.